Search

everythinglearnresearchcommunity

for

Search:↓

Platelet-rich plasma treatment significantly increased hair regrowth and decreased discomfort in alopecia patients, making it a potentially better and safer treatment option.

Topical procyanidin B2 significantly increases hair count and is a safe treatment for male pattern baldness.

Cyproterone acetate is effective for treating hirsutism and acne but less so for hair loss, with side effects similar to birth control pills.

Inhibiting PLA2 enzymes may help treat inflammatory skin diseases like psoriasis and dermatitis.

TGPC plus CGT is effective and safe for treating severe alopecia areata in children.

Topical DPCP is somewhat effective for hair loss in alopecia areata, but more research is needed.

Inhibiting ACE2 improves skin regeneration during tissue expansion.

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.

PEA boosts allopregnanolone production and reduces oxidative stress in brain cells.

PRP therapy can temporarily grow hair in CCCA patients but isn't a permanent cure.

A new gene mutation linked to a skin condition was found in a Spanish family.

A patient with PPP had rare skin reactions to adalimumab, which improved after stopping smoking and continuing acitretin.

Polynucleotides HPT improves Asian skin tone, firmness, and glow safely.

1′S-1′-Acetoxychavicol acetate may help treat hair loss by reducing oxidative stress.

Upadacitinib may effectively treat resistant lichen planopilaris.

Activated and non-activated PRP are equally safe and effective for treating alopecia areata.

CCCA is a common hair loss condition in African American women, often inherited and influenced by hairstyling, with unique scalp features detectable by special tools.

The 2018 ISPAN Meeting emphasized hands-on learning, patient safety, and professional growth in medical aesthetics and reconstructive practices.

GMG-43AC may help reduce unwanted hair growth and treat certain hair loss conditions.

PDLLA scalp injections improved hair regrowth in most patients with non-scarring alopecia.

Different types of PPARγ are found in varying amounts in human skin and its parts, which could affect how skin treatments work.

CD2 might be a new treatment target for patchy alopecia areata.

PRP is effective for treating patchy alopecia areata.

Platelet-Rich Plasma (PRP) may help improve hair density in primary cicatricial alopecias (PCAs) patients, but more trials are needed to confirm its benefits.

Compounds from Pterocarpus indicus may help treat benign prostatic hyperplasia by stopping cell growth.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

The document's content cannot be summarized because it is not accessible or understandable.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

AP collagen peptides may help hair grow better and become stronger.